How Is the China Biopharmaceuticals Market Driving Innovation in Oncology and Immuno‑Oncology?
The China Biopharmaceuticals Market is a key driver of innovation in oncology and immuno‑oncology, where Chinese‑companies are developing novel‑targets, combination‑therapies, and precision‑medicine‑approaches. With one of the largest cancer‑burdens in the world, China has a strong clinical‑need‑and‑incentive‑structure that supports rapid‑trial‑enrollment, biomarker‑research, and...
0 Commentaires 0 Parts 194 Vue 0 Aperçu